Description     Claims     Drawing  

WO2016070166A   [0003] 
WO2011068810A   [0003]  [0079] 
WO2010053572A   [0064]  [0079] 
WO2012170930A   [0064] 
US61617468   [0064]  [0079] 
WO2013063468A   [0065] 
US61953516   [0065] 
US4897355A   [0077] 
US5171678A   [0077] 
US5334761A   [0077] 
WO2010042877A   [0078] 
WO2005121348A1   [0078] 
WO2012170889A   [0079] 
WO61617468A   [0079] 
US5744335A   [0083] 
US5885613A   [0084] 
US4373071A   [0092] 
US4401796A   [0092] 
US4415732A   [0092] 
US4458066A   [0092] 
US4500707A   [0092] 
US4668777A   [0092] 
US4973679A   [0092] 
US5047524A   [0092] 
US5132418A   [0092] 
US5153319A   [0092] 
US5262530A   [0092] 
US5700642A   [0092] 
US8093367B   [0108] 
US8304529B   [0108] 
US4737323A   [0123] 
US1241663W   [0134] 
WO62349331A   [0183] 
WO62509568A   [0183] 

J. Pharmaceutical Sciences   [0038] 
Trends Biotechnol.   [0063] 
Bioinspired Alkenyl Amino Alcohol Ionizable Lipid Materials for Highly Potent In Vivo mRNA Delivery   [0076] 
Proc. Nat'l Acad. Sci.   [0077] 
Proc. Nat.'l Acad. Sci.   [0077] 
Nature Biotech.   [0078] 
J Controlled Release   [0078] 
Nat. Biotechnol.   [0078] 
Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids   [0079]  [0149] 
Rational Design of Cationic Lipids for siRNA Delivery   [0079]  [0149] 
Lipid-like materials for low-dose in vivo gene silencing   [0079]  [0149] 
Biochem. Biophys. Res. Comm.   [0083] 
BioTechniques   [0083] 
FEBS Letters   [0084] 
Novel 'anti-reverse' cap analogs with superior translational properties   [0105] 
RNA   [0108] 
RNA   [0108] 
RNA   [0108] 
Nature Biotechnology   [0109] 
Molecular Cloning A Laboratory Manual   [0109] 
FEBS Lett.   [0118] 
Ann. Rev. Biophys. Bioeng.   [0123] 
Remington's Pharmaceutical Sciences   [0124] 
Recognition of mRNA cap structures by viral and cellular proteins   [0150]